Quality of global e-pharmacies: can we safeguard consumers?

被引:31
作者
Bessell, TL
Silagy, CA
Anderson, JN
Hiller, JE
Sansom, LN
机构
[1] Monash Univ, Inst Hlth Serv Res, Clayton, Vic 3168, Australia
[2] Univ Adelaide, Dept Publ Hlth, Adelaide, SA 5005, Australia
[3] Univ S Australia, Sch Pharmaceut Mol & Biomed Sci, Adelaide, SA 5000, Australia
关键词
Internet; quality; regulation;
D O I
10.1007/s00228-002-0519-5
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objective: E-pharmacies are web sites selling prescription-only medicines and other products including non-prescription and complementary medicines to consumers via the internet. This study aims to evaluate the quality of global e-pharmacies, discuss whether e-pharmacies support the safe and appropriate use of medicines, and consider how we can protect consumers in the future. Methods: A survey of public information published on global e-pharmacy web sites was conducted between July and September 2001. We used a meta-search engine, Copernic, and the search terms of 'online' or 'internet', and 'pharmacy', 'pharmacies' and 'medicines' to identify a sampling frame of global e-pharmacies. We surveyed all web sites in the sampling frame except those under construction or only offering electronic refills, members-only and non-English web sites. Survey data included country of origin, range of medicines sold, prescription requirements, availability of online medical consultations and pharmacists' advice, quality accreditation seals, policies and advertisements. Results: E-pharmacies operated in at least 13 countries; however, the country of origin could not be identified for 22 web sites. Twenty web sites (19%) appeared to supply prescription-only medicines with no prescription required. Only 12% of e-pharmacies displayed quality accreditation seals. We observed information published on e-pharmacy web sites that potentially undermines the safe and appropriate use of medicines. Conclusion: Safeguarding consumers and ensuring the quality of web sites that sell medicines across state and national boundaries is both complex and difficult. Strategies to improve the quality of e-pharmacies include independent third-party regulation of providers, evaluation and enforcement of sanctions in cases of dissemination of fraudulent or harmful information and practices, self-regulation and consumer education. The development of internet regulatory technologies themselves and the resolution of jurisdictional issues offer future solutions but international co-operation is vital.
引用
收藏
页码:567 / 572
页数:6
相关论文
共 28 条
[1]   Direct sale of sildenafil (Viagra) to consumers over the Internet [J].
Armstrong, K ;
Schwartz, JS ;
Asch, DA .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (18) :1389-1392
[2]  
*AUSTR HLTH MIN AD, 1997, GUID NAT DRUGS POIS
[3]  
*AUSTR PHARM MAN A, 2000, COD COND
[4]   Internet availability of prescription pharmaceuticals to the public [J].
Bloom, BS ;
Iannacone, RC .
ANNALS OF INTERNAL MEDICINE, 1999, 131 (11) :830-+
[5]  
*CAN PHARM ASS, 2000, STAT INT PHARM CAN
[6]   THE QUALITY OF CARE - HOW CAN IT BE ASSESSED [J].
DONABEDIAN, A .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1988, 260 (12) :1743-1748
[7]   Recent advances - Consumer health informatics [J].
Eysenbach, G .
BMJ-BRITISH MEDICAL JOURNAL, 2000, 320 (7251) :1713-1716
[8]   Online Prescribing of Sildanefil (Viagra) on the World Wide Web [J].
Eysenbach, Gunther .
JOURNAL OF MEDICAL INTERNET RESEARCH, 1999, 1 (02) :36-39
[10]  
GORTON S, 2000, US SENATE DRUG PRICI